Dr Corp (301177.SZ) Stock Price
Dr Corp Price
Revenue has compounded at 0.2% per year over the past 7 years to 1.52 B CNY. Earnings per share have declined at 9.2% per year over the last 7 years. Dr Corp's net margin stands at 9.2%, down from 28.2% several years earlier. Dr Corp currently offers a dividend yield of about 2.16%. The payout ratio is around 144% of earnings. Analysts set a median price target of 35.23 CNY, implying 52.1% above the current price. Of 7 analysts, 4 rate the stock a buy — an overall Buy consensus.
Dr Corp stock price
Dr Corp business model & stock analysis
Frequently asked questions about Dr Corp
Analysts currently set an average price target of 35.23 CNY for the Dr Corp stock (median: 35.23 CNY), implying +52.1 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Dr Corp stock: 4 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Dr Corp to generate revenue of 1.61 B CNY and earnings per share of 0.51 CNY.
Converted at the current exchange rate, the Dr Corp share trades at 3.06 EUR (23.16 CNY).
The expected revenue of Dr Corp is 1.61 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Dr Corp is 204.01 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Dr Corp is currently 45.41. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Dr Corp stock.
The price-to-sales ratio (P/S) of Dr Corp is currently 5.76. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Dr Corp stock.
The Eulerpool Quality Score for Dr Corp is 1/10.
The ISIN of Dr Corp is CNE100005501. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Dr Corp is 301177.SZ. The ticker symbol is used to trade Dr Corp shares on the stock exchange.
Dr Corp stock
Dr Corp Peer Group
Dr Corp FIGI
All fundamentals and in-depth analysis of Dr Corp
Our stock analysis for Dr Corp stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dr Corp. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.